Search Results 1511-1520 of 14739 for anti-TNF drugs

1. Folate Receptor Alpha Peptide Vaccine With GM-CSF Versus GM-CSF Alone in Patients With Platinum Sensitive Ovarian Cancer - Mayo Clinic

   Receipt of the last dose of anti-cancer therapy (chemotherapy, immunotherapy, targeted therapy, biological/cell therapy, tumor embolization, monoclonal ...

2. A Study to Evaluate the Safety and Effectiveness of OMS721 in Patients with Immunoglobulin A (IgA) Nephropathy - Mayo Clinic

   The study will assess proteinuria by 24-hour urine protein excretion (UPE) in g/day at 36 weeks from beginning of treatment. Participation eligibility.

3. A Study to Assess the Safety and Antitumor Activity of Genetically Engineered T Cells in NY-ESO-1 and/or LAGE-1a Positive Solid Tumors - Mayo Clinic

   About this study. To evaluate the effectiveness of NY-ESO-1-Specific (c259) T Cells, alone or in combination with other anti-cancer agents, in HLA-A*02:01, ...

4. Once-daily Oral VT-464 in Patients With Castration-Resistant Prostate Cancer Progressing on Enzalutamide or Abiraterone. - Mayo Clinic

   ... anti-seizure medications are excluded. History of loss of consciousness or transient ischemic attack within 12 months before study drug initiation. Patients ...

5. Sulfadiazine (Oral Route) Proper Use - Mayo Clinic

   For treatment of infections: Adults—2000 to 4000 milligrams (mg) per day, divided and given in 3 to 6 doses per day. Children and infants 2 ...

6. Emtricitabine (Oral Route) Precautions - Mayo Clinic

   These are more common if you are female, very overweight (obese), or have been taking anti-HIV medicines for a long time. Call your doctor right away if you ...

7. Depression and anxiety: Can I have both? - Mayo Clinic

   Symptoms of both conditions usually improve with psychological counseling (psychotherapy), medications, such as antidepressants, or both. Lifestyle changes, ...

8. The ExTINGUISH Trial of Inebilizumab in NMDAR Encephalitis (ExTINGUISH) - Mayo Clinic

   There are currently no medicinal products approved for the treatment of anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis, a rare disease. NMDAR ...

9. A Study of Idasanutlin in Combination With Obinutuzumab in Relapsed/Refractory (R/R) Follicular Lymphoma (FL) and in Combination With Rituximab in R/R Diffuse Large B-Cell Lymphoma (DLBCL) Participants - Mayo Clinic

   Drugs & Supplements A-Z · Health Books · Healthy ... By condition, treatment or drug name. Search ... anti-CD20 monoclonal antibody (mAb) and for which ...

10. Probenecid (Oral Route) Proper Use - Mayo Clinic

    Proper Use. Drug information provided by: Merative, Micromedex®. If probenecid upsets your stomach, it may be taken with food. If this does not work, ...